NSC vs VIR · P/E 18, rev $6.46B vs rev $238.9M
Norfolk Southern Corporation (NSC) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
NSC currently screens at market cap $60.10B and trailing P/E 18.2. VIR currently screens at market cap $1.45B.
Not investment advice. Open the NSC and VIR stock pages for the full models.
Not investment advice.